Cardiovascular Health and Supplementation
Diet, physical activity, smoking cessation and indicated medicines remain central to cardiovascular prevention and treatment. Supplements do not replace statins, blood-pressure medicines, anticoagulants or heart-failure therapy. Distinguish a change in a risk marker from evidence that an intervention prevents heart attacks, strokes or deaths.
CoQ10: Selected Heart-Failure Evidence
Q-SYMBIO randomized 420 patients with moderate-to-severe heart failure to CoQ10 100 mg three times daily or placebo in addition to standard treatment for two years. The primary composite endpoint occurred in 15% versus 26% (hazard ratio 0.50, 95% CI 0.32–0.80). Cardiovascular deaths were 9% versus 16%, and all-cause deaths 10% versus 18%; short-term endpoints at 16 weeks did not significantly differ [1].
These results are promising in the studied population, but do not establish routine prevention benefits or justify replacing guideline-directed therapy. NCCIH describes the overall heart-failure evidence as inconclusive [7].
A 2018 meta-analysis reported improvement in statin-associated muscle symptoms [6], but other evidence conflicts, and NCCIH does not support routine use for statin muscle pain [7]. Neither age over 40 nor statin use establishes a need for ubiquinol. Discuss symptoms and medication management with the prescriber; CoQ10 can interact with warfarin and insulin [7].
Omega-3 Fatty Acids: Prescription Evidence Has a Specific Scope
REDUCE-IT studied 8,179 statin-treated patients with elevated triglycerides and established cardiovascular disease or diabetes plus other risk factors. Prescription icosapent ethyl, 4 g/day, reduced the primary composite event rate from 22.0% to 17.2% over a median 4.9 years (hazard ratio 0.75) [2]. Atrial fibrillation/flutter hospitalization was more frequent; bleeding also requires consideration.
That result cannot be assigned to arbitrary EPA/DHA supplements. Large trials of ordinary-dose EPA/DHA have not consistently reduced major cardiovascular events, and ingredient amounts vary by product [8]. Prescription omega-3 therapy for high triglycerides is a clinician-managed intervention, not a reason to multiply over-the-counter capsules or recommend 1 g/day to everyone.
Magnesium: A Modest Blood-Pressure Effect
Zhang and colleagues’ 2016 Hypertension meta-analysis included 34 trials and 2,028 participants. At a median 368 mg/day for three months, systolic pressure fell about 2.00 mmHg and diastolic pressure 1.78 mmHg versus placebo [3]. This average marker change does not establish prevention of cardiovascular events or a universal supplement requirement.
Serum magnesium does not fully represent body stores, but a low dietary intake is not the same as a proven deficiency. No form has been established as the universally best cardiovascular option. Supplemental magnesium can cause diarrhea, accumulate with impaired kidney function and interact with medicines; the U.S. adult upper limit for supplemental/medication magnesium is 350 mg/day unless a clinician directs otherwise [9].
Vitamin K2: Mechanism and Association Are Not Prevention Proof
Vitamin K-dependent proteins participate in coagulation and bone and vascular biology. The Rotterdam Study associated higher dietary menaquinone intake with lower coronary mortality, but it was observational and did not test a K2 supplement [4]. Such associations cannot establish that taking MK-7 prevents heart attacks or arterial calcification.
NIH ODS considers the role of different vitamin K forms in arterial calcification and coronary disease uncertain [10]. There is no established K2 dose for cardiovascular prevention. People taking warfarin should keep vitamin K intake consistent and discuss any change with their anticoagulation team.
Psyllium: Evidence for LDL Lowering
A 2018 meta-analysis included 28 trials and 1,924 participants. A median psyllium dose of about 10.2 g/day lowered LDL cholesterol by 0.33 mmol/L (about 13 mg/dL; 95% CI 0.27–0.38 mmol/L lower) [5]. These trials measured lipid markers, not a demonstrated reduction in heart attacks from that regimen.
Soluble fiber can complement a cholesterol-lowering diet [11]. Follow product instructions for adequate fluid, review swallowing or bowel problems and separate medicines as directed by a clinician or pharmacist. A lower LDL result does not replace indicated drug therapy.
Choosing an Appropriate Role
The useful question is whether a specific intervention addresses a diagnosed problem with evidence relevant to that person. Prescription EPA in selected high-risk patients, adequate nutrient intake and soluble fiber are different decisions. CoQ10 and K2 should not be presented as routine additions for every adult or every statin user.